Cellular Biomedicine (CBMG) Stock Analyst Ratings
NASDAQ:CBMG - Nasdaq -
ChartMill assigns a Buy % Consensus number of 60% to CBMG. The Buy consensus is the weighted average rating of the current analysts ratings.
CBMG was analyzed by 1 analysts. The buy percentage consensus is at 60. So analysts seem to be rather neutral about CBMG.
In the previous month the buy percentage consensus was at a similar level.
Only 1 analysts analyzed CBMG. So this is just the average opinion of a couple of analysts.